University of Wisconsin–Madison Medical College of Wisconsin

Wisconsin Young Adults’ Attitudes, Beliefs, Motivations, and Behaviors Surrounding E-Cigarette Use and Cessation

Jesse T. Kaye, PhD; Brian S. Williams, MD; Jennifer Bird, PhD; Karen L. Conner, MPH; Rob Adsit, MEd; Megan E. Piper, PhD

WMJ. 2025;124(2):129-134

Download full-text pdf.

ABSTRACT

Introduction: Electronic cigarette (e-cigarette) use is prevalent among young adults, yet cessation treatment options are limited and underutilized.

Methods: Wisconsin residents aged 18 to 24 who had vaped nicotine in the past month (N = 480) completed an online survey assessing vaping initiation, past quit experiences, future quit intentions, and treatment knowledge and preferences. The survey also assessed perceived physical and mental health harms of vaping nicotine and other products (eg, cannabis, cannabidiol).

Results: Most young adults had made a prior e-cigarette quit attempt, commonly motivated by concerns about addiction, cost, and health problems. Though 80% want support to quit, preferred methods of support were highly variable. The same methods (eg, medication, friends/family, health care provider, therapist) that were most endorsed as the form of support young adults were most likely to use were also among the most endorsed forms of support that young adults would not want to use. Nearly 40% of participants reported vaping cannabis and perceived vaping cannabis as significantly less harmful than vaping nicotine or tobacco for physical and mental health.

Conclusions: Vaping cessation resources that are responsive to young adults’ needs and preferences are needed. The high variability in treatment preferences suggests that multiple strategies need to be offered; there is no one-size-fits-all approach. Cannabis vaping is prevalent, and an important area for future research is to examine the impact of cannabis vaping on nicotine vaping dependence, cessation, and treatment use. Strategies to reach, motivate, and engage young adults in e-cigarette cessation and cessation treatment should highlight their concerns about addiction, costs, health harms, and desired treatment options.


Author Affiliations: Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health (UWSMPH), Madison, Wisconsin (Kaye, Williams, Conner, Adsit, Piper); Division of General Internal Medicine, Department of Medicine, UWSMPH, Madison, Wisconsin (Kaye, Conner, Adsit, Piper); Division of Hospital Medicine and Complex Care, Department of Pediatrics, UWSMPH, Madison, Wisconsin (Williams); Division of Hospital Medicine, Department of Medicine, UWSMPH, Madison, Wisconsin (Williams); Carbone Cancer Center, UWSMPH, Madison, Wisconsin (Bird).
Corresponding Author: Jesse T. Kaye, PhD, 1930 Monroe St, #200, Madison, WI 53711; phone 608.262.8885; email jtkaye@wisc.edu; ORCID ID 0000-0001-6350-4247
Financial Disclosures: Megan Piper, PhD, reports receiving consulting fees from Temple University, New York University, University of South Carolina, and University of Waterloo and grand rounds speaker payments or honoraria from University of Alabama Birmingham and Roswell Park.
Funding/Support: Funding for this study was provided by Wisconsin Department of Health Services, MSN276077.
Share WMJ